# Factors Affecting PrEP Adherence

> **NCT02411630** · — · COMPLETED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 167 (actual)

## Conditions studied

- HIV Infection

## Interventions

- **DRUG:** Emtricitabine/tenofovir disoproxil

## Key facts

- **NCT ID:** NCT02411630
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 167 (ACTUAL)
- **Last updated:** 2017-02-28

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02411630

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02411630, "Factors Affecting PrEP Adherence". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02411630. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*